A carregar...
LY3045697: Results from two randomized clinical trials of a novel inhibitor of aldosterone synthase
INTRODUCTION: LY3045697 is a potent and selective aldosterone synthase (CYP11B2) inhibitor that was developed as a safer alternative to mineralocorticoid receptor antagonists. Effects of LY3045697 on aldosterone and cortisol synthesis, as well as potassium ion homeostasis, were evaluated in two clin...
Na minha lista:
| Publicado no: | J Renin Angiotensin Aldosterone Syst |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5843917/ https://ncbi.nlm.nih.gov/pubmed/28814143 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1470320317717883 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|